Your browser doesn't support javascript.
loading
Clinical Outcomes in Patients with Rheumatoid Arthritis After Switching Between Interleukin-6-Receptor Inhibitors and Janus Kinase Inhibitors: Findings from an Observational Study.
Dua, Anisha B; Ford, Kerri; Fiore, Stefano; Pappas, Dimitrios A; Janak, Jud C; Blachley, Taylor; Roberts-Toler, Carla; Emeanuru, Kelechi; Kremer, Joel M; Kivitz, Alan.
Afiliação
  • Dua AB; Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. anisha.dua@northwestern.edu.
  • Ford K; Medical Affairs, Sanofi, Cambridge, MA, USA.
  • Fiore S; Medical Affairs, Sanofi, Bridgewater, NJ, USA.
  • Pappas DA; CorEvitas, LLC, Waltham, MA, USA.
  • Janak JC; Division of Rheumatology, Columbia University, New York, NY, USA.
  • Blachley T; Corrona Research Foundation, Waltham, MA, USA.
  • Roberts-Toler C; CorEvitas, LLC, Waltham, MA, USA.
  • Emeanuru K; CorEvitas, LLC, Waltham, MA, USA.
  • Kremer JM; CorEvitas, LLC, Waltham, MA, USA.
  • Kivitz A; CorEvitas, LLC, Waltham, MA, USA.
Rheumatol Ther ; 10(6): 1753-1768, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37906399
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article